You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
麗珠醫藥(01513.HK):首次授予第一個行權期開始行權 行權價格36.16元/A股
格隆匯 11-20 23:19

格隆匯11月20日丨麗珠醫藥(01513.HK)公佈,首次授予股票期權的授予日為2018年9月11日,授予登記完成日為2018年9月28日,首次授予股票期權的第一個等待期已於2019年9月27日屆滿。

2019年9月18日,董事會認為首次授予第一個行權期的行權條件已經成就,同意符合行權條件的1,033名激勵對象在第一個行權期可行權898.5262萬份股票期權,行權價格為人民幣36.16元/A股。

2019年11月20日,經深圳證券交易所及中國證券登記結算有限責任公司深圳分公司審核,首次授予第一個行權期的股票期權將於2019年11月22日開始可以行權。此次可行權的股票期權簡稱:麗珠JLC1,股票期權代碼:037067。

首次授予第一個行權期的股票期權的行權期限自2019年11月22日至2020年9月27日止。可行權日必須為交易日,因此該次可行權期限最後一個交易日為2020年9月25日。激勵對象必須在行權期限內行權完畢,行權期限結束後,已獲授但尚未行權的股票期權不得行權。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account